• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NPM1 在高倍体多发性骨髓瘤中由于 5 号染色体获得而过度表达,但不会向细胞质移位。

NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm.

机构信息

Medizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany.

出版信息

Genes Chromosomes Cancer. 2010 Apr;49(4):333-41. doi: 10.1002/gcc.20745.

DOI:10.1002/gcc.20745
PMID:20073075
Abstract

Multiple myeloma (MM) is proposed to consist of two main pathogenetic groups. Although hyperdiploid MM (HD) is characterized by multiple trisomies of odd chromosomes, in nonhyperdiploid MM (NHD), one of the recurrent primary immunoglobulin heavy chain (IGH) translocations and deletion of chromosome 13 can frequently be found. In this study, we analyzed gene-expression profiles of patients with previously untreated MM. Fifty-four genes were significantly differentially expressed between the two groups. NPM1 was upregulated in HD. The differential expression of 25 genes, including NPM1 and 13 ribosomal protein genes, was validated using a published gene expression data set. The overexpression of NPM1 in HD was further confirmed by quantitative real-time PCR and Western blotting. NPM1 was significantly overexpressed in HD as the result of a gain of chromosome 5. Insertions into exon 12 of NPM1 were not detected. NPM1 was localized to the nucleoli of MM cells. Furthermore, HD was associated with an overexpression of ribosomal protein genes, independent of their localization on the trisomic or other chromosomes. Our results indicate that the gain of chromosome 5 might play an important role in the pathogenesis of HD.

摘要

多发性骨髓瘤(MM)被认为由两个主要的发病机制群组成。虽然超二倍体 MM(HD)的特征是多个奇数染色体的三体,但在非超二倍体 MM(NHD)中,经常可以发现其中一种复发性主要免疫球蛋白重链(IGH)易位和 13 号染色体缺失。在这项研究中,我们分析了未经治疗的 MM 患者的基因表达谱。两组之间有 54 个基因的表达存在显著差异。NPM1 在 HD 中上调。使用已发表的基因表达数据集验证了包括 NPM1 和 13 个核糖体蛋白基因在内的 25 个基因的差异表达。通过定量实时 PCR 和 Western blot 进一步证实了 HD 中 NPM1 的过表达。NPM1 的过表达是由于获得了 5 号染色体。未检测到 NPM1 插入 12 外显子。NPM1 定位于 MM 细胞的核仁中。此外,HD 与核糖体蛋白基因的过度表达有关,而与它们在三体或其他染色体上的定位无关。我们的结果表明,5 号染色体的获得可能在 HD 的发病机制中起重要作用。

相似文献

1
NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm.NPM1 在高倍体多发性骨髓瘤中由于 5 号染色体获得而过度表达,但不会向细胞质移位。
Genes Chromosomes Cancer. 2010 Apr;49(4):333-41. doi: 10.1002/gcc.20745.
2
Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma.翻译机制的上调和不同的基因亚组是多发性骨髓瘤中高倍体的特征。
Br J Haematol. 2007 Feb;136(4):565-73. doi: 10.1111/j.1365-2141.2006.06467.x.
3
Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.多发性骨髓瘤中常见获得性/扩增性染色体区域中过表达基因的鉴定。
Haematologica. 2006 Feb;91(2):184-91.
4
Cytogenetics and molecular cytogenetics in multiple myeloma.多发性骨髓瘤中的细胞遗传学和分子细胞遗传学
Eur J Cancer. 2006 Jul;42(11):1520-9. doi: 10.1016/j.ejca.2005.12.028. Epub 2006 Jun 16.
5
Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.通过整合基因组学对人多发性骨髓瘤细胞系进行分子特征分析:对疾病生物学的见解
Genes Chromosomes Cancer. 2007 Mar;46(3):226-38. doi: 10.1002/gcc.20404.
6
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.对人类骨髓瘤细胞系进行的综合高分辨率微阵列分析揭示了与等位基因失衡和基因表达谱相关的miRNA表达失调。
Genes Chromosomes Cancer. 2009 Jun;48(6):521-31. doi: 10.1002/gcc.20660.
7
Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.多发性骨髓瘤的分子分类:一种独特的转录谱特征表现于表达CCND1且14q32易位阴性的患者。
J Clin Oncol. 2005 Oct 10;23(29):7296-306. doi: 10.1200/JCO.2005.01.3870. Epub 2005 Aug 29.
8
Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.细胞周期蛋白D1的过表达不是一个特异性的分组标志物,但可能在骨髓瘤细胞中与CDC37协同作用。
Int J Oncol. 2004 Sep;25(3):579-95.
9
Identification of primary MAFB target genes in multiple myeloma.多发性骨髓瘤中主要MAFB靶基因的鉴定。
Exp Hematol. 2009 Jan;37(1):78-86. doi: 10.1016/j.exphem.2008.08.006. Epub 2008 Nov 13.
10
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.一种用于检测多发性骨髓瘤中等位基因失衡的单核苷酸多态性微阵列和基于荧光原位杂交的方法:一种综合基因组学方法揭示了广泛的基因剂量效应。
Genes Chromosomes Cancer. 2009 Jul;48(7):603-14. doi: 10.1002/gcc.20668.

引用本文的文献

1
A neutrophil extracellular trap-related risk score predicts prognosis and characterizes the tumor microenvironment in multiple myeloma.一种与中性粒细胞胞外诱捕网相关的风险评分可预测多发性骨髓瘤的预后并描绘其肿瘤微环境特征。
Sci Rep. 2024 Jan 27;14(1):2264. doi: 10.1038/s41598-024-52922-7.
2
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.单细胞转录组学揭示难治性多发性骨髓瘤中亚克隆特异性的微环境影响和药物反应。
Nat Commun. 2021 Nov 29;12(1):6960. doi: 10.1038/s41467-021-26951-z.
3
Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets.
多发性骨髓瘤细胞系和原发性肿瘤蛋白质组:蛋白质生物合成与免疫系统作为潜在治疗靶点
Genes Cancer. 2015 Nov;6(11-12):462-471. doi: 10.18632/genesandcancer.88.
4
A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.一种新型邻苯二甲酰亚胺衍生物TC11对高危骨髓瘤细胞和破骨细胞具有临床前效应。
PLoS One. 2015 Jan 24;10(1):e0116135. doi: 10.1371/journal.pone.0116135. eCollection 2015.